Skoči na glavni sadržaj

Pregledni rad

https://doi.org/10.24869/psyd.2020.325

THERAPEUTIC MECHANISMS OF KETAMINE

Slobodan Mihaljević ; Department of Anaesthesiology, Reanimatology and Intensive Care Medicine, University Hospital Centre Zagreb, Zagreb, Croatia
Matko Pavlović ; Department of Psychiatry, General Hospital Bjelovar, Bjelovar, Croatia
Krešimir Reiner ; Department of Anesthesiology and Intensive Care Medicine, Clinic for Obstetrics and Gynecology, University Clinical Hospital Centre Zagreb, Zagreb, Croatia
Marko Ćaćić


Puni tekst: engleski pdf 136 Kb

str. 325-333

preuzimanja: 815

citiraj


Sažetak

Major depressive disorder is the greatest burden of developed countries in the context of morbidity caused by mental disorders. Until recent, ketamine has been mostly used for anesthesia, analgesia, sedation and treatment of chronic pain syndromes. However, unique pharmacodynamic properties of ketamine have increased interests in it's use for treatment of depression. It is assumed that ketamine reverses synaptic chronic stress pathology within one day of administration by postsynaptic glutamate activation, providing synaptic connectivity restoration that last for days or weeks. Potential glutamatergic agents, in context of treatment of major depressive disorder are not entirely novel phenomenon. Considering the aforementioned, current neurobiological view of depression as a solely monoaminergic phenomenon should be reassessed in order to prompt discovery of putative antidepressant drugs of novel generation. Acute side effects, such as increased salivation, increase in heart rate, systemic arterial pressure and intracranial pressure necessitate careful monitoring during intravenous administration of ketamine, even in subanesthetic doses. However, major burden of ketamine administration lies in it's ability to produce psychotomimetic side effects and emergence delirium. Esketamine nasal spray has now been widely approved and is considered safe in terms of acute side effects, tolerability and consistent therapeutic benefit.

Ključne riječi

ketamine; depression; neurobiology

Hrčak ID:

250625

URI

https://hrcak.srce.hr/250625

Datum izdavanja:

7.1.2021.

Posjeta: 1.661 *